Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction

Clinical trial NCT00365157 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT00365157
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Urothelial Carcinoma Locally Advanced Urothelial Carcinoma Metastatic Urothelial Carcinoma Recurrent Urothelial Carcinoma Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 Stage IV Bladder Urothelial Carcinoma AJCC v7 Unresectable Urothelial Carcinoma

Start date: 2006-10-23
Primary completion: 2025-07-09
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.